Eurobio Scientific Société anonyme (ALERS.PA)
EUR 23.8
(-5.93%)
EUR 23.8
(-5.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 51.33 Million EUR | -22.35% |
| 2022 | 66.11 Million EUR | 185.59% |
| 2021 | -77.24 Million EUR | -118.19% |
| 2020 | -35.4 Million EUR | -389.49% |
| 2019 | 12.22 Million EUR | -11.59% |
| 2018 | 13.83 Million EUR | 32.71% |
| 2017 | 10.42 Million EUR | 1884.76% |
| 2016 | -584 Thousand EUR | -126.09% |
| 2015 | 2.23 Million EUR | -61.96% |
| 2014 | 5.88 Million EUR | 702.77% |
| 2013 | -976 Thousand EUR | 74.68% |
| 2012 | -3.85 Million EUR | 49.15% |
| 2011 | -7.57 Million EUR | -52.37% |
| 2010 | -4.97 Million EUR | -178.5% |
| 2009 | -1.78 Million EUR | -119.56% |
| 2008 | 9.13 Million EUR | 8.5% |
| 2007 | 8.41 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 43.05 Million EUR | 0.0% |
| 2023 Q2 | 64.95 Million EUR | 0.0% |
| 2023 FY | 51.33 Million EUR | -22.35% |
| 2023 Q4 | 51.33 Million EUR | 0.0% |
| 2022 Q4 | 66.11 Million EUR | 0.0% |
| 2022 FY | 66.11 Million EUR | 185.59% |
| 2022 Q2 | -82.6 Million EUR | 0.0% |
| 2021 Q4 | -77.24 Million EUR | 0.0% |
| 2021 FY | -77.24 Million EUR | -118.19% |
| 2021 Q2 | -55.11 Million EUR | 0.0% |
| 2020 FY | -35.4 Million EUR | -389.49% |
| 2020 Q4 | -35.4 Million EUR | 0.0% |
| 2020 Q2 | 15.62 Million EUR | 0.0% |
| 2019 Q2 | 14.31 Million EUR | 0.0% |
| 2019 Q4 | 12.22 Million EUR | 0.0% |
| 2019 FY | 12.22 Million EUR | -11.59% |
| 2018 Q4 | 13.83 Million EUR | 0.0% |
| 2018 FY | 13.83 Million EUR | 32.71% |
| 2018 Q2 | 15.09 Million EUR | 0.0% |
| 2017 Q4 | 10.42 Million EUR | 0.0% |
| 2017 FY | 10.42 Million EUR | 1884.76% |
| 2017 Q2 | 7.82 Million EUR | 0.0% |
| 2016 Q4 | -584 Thousand EUR | 0.0% |
| 2016 Q2 | 2 Million EUR | 0.0% |
| 2016 FY | -584 Thousand EUR | -126.09% |
| 2015 FY | 2.23 Million EUR | -61.96% |
| 2015 Q4 | 2.23 Million EUR | 0.0% |
| 2015 Q2 | 4.73 Million EUR | 0.0% |
| 2014 Q4 | 5.88 Million EUR | 0.0% |
| 2014 FY | 5.88 Million EUR | 702.77% |
| 2014 Q2 | 231 Thousand EUR | 0.0% |
| 2013 Q2 | -644 Thousand EUR | 0.0% |
| 2013 FY | -976 Thousand EUR | 74.68% |
| 2013 Q4 | -976 Thousand EUR | 0.0% |
| 2012 Q4 | -3.85 Million EUR | -300.0% |
| 2012 Q1 | -963.5 Thousand EUR | 87.29% |
| 2012 FY | -3.85 Million EUR | 49.15% |
| 2012 Q2 | -8.73 Million EUR | -807.01% |
| 2012 Q3 | -963.5 Thousand EUR | 88.97% |
| 2011 Q1 | -1.89 Million EUR | 61.91% |
| 2011 FY | -7.57 Million EUR | -52.37% |
| 2011 Q4 | -7.57 Million EUR | -300.0% |
| 2011 Q3 | -1.89 Million EUR | -336.25% |
| 2011 Q2 | 802 Thousand EUR | 142.33% |
| 2010 Q1 | -1.24 Million EUR | 30.38% |
| 2010 Q2 | -9.99 Million EUR | -703.7% |
| 2010 Q3 | -1.24 Million EUR | 87.56% |
| 2010 Q4 | -4.97 Million EUR | -300.0% |
| 2010 FY | -4.97 Million EUR | -178.5% |
| 2009 Q4 | -1.78 Million EUR | -300.0% |
| 2009 Q3 | -446.5 Thousand EUR | 0.0% |
| 2009 Q2 | -446.5 Thousand EUR | 0.0% |
| 2009 Q1 | -446.5 Thousand EUR | -119.56% |
| 2009 FY | -1.78 Million EUR | -119.56% |
| 2008 Q3 | 2.28 Million EUR | 0.0% |
| 2008 Q1 | 2.28 Million EUR | 8.5% |
| 2008 Q2 | 2.28 Million EUR | 0.0% |
| 2008 FY | 9.13 Million EUR | 8.5% |
| 2008 Q4 | 2.28 Million EUR | 0.0% |
| 2007 Q2 | 2.1 Million EUR | 0.0% |
| 2007 FY | 8.41 Million EUR | 0.0% |
| 2007 Q1 | 2.1 Million EUR | 0.0% |
| 2007 Q4 | 2.1 Million EUR | 0.0% |
| 2007 Q3 | 2.1 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | -231.694% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | 5994.741% |
| Carmat SA | 49.63 Million EUR | -3.419% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | -345.29% |
| Euromedis Groupe | -8.82 Million EUR | 681.601% |
| Ikonisys S.A. | 3.19 Million EUR | -1505.11% |
| Implanet S.A. | 5.9 Million EUR | -769.609% |
| Median Technologies SA | 3.5 Million EUR | -1364.147% |
| SpineGuard SA | 215.79 Thousand EUR | -23687.634% |
| Theraclion SA | -5.86 Million EUR | 975.312% |
| Euroapi S.A. | 191 Million EUR | 73.124% |
| Guerbet SA | 332.59 Million EUR | 84.566% |
| Ion Beam Applications SA | -67.72 Million EUR | 175.798% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 99.118% |
| Sequana Medical NV | 14.2 Million EUR | -261.429% |